Project Details
Description
A Multicenter, Open-label, Long-term Extension Study for Oral Levosimendan (TNX-103)
| Status | Active |
|---|---|
| Effective start/end date | 1/27/26 → 1/26/37 |
Funding
- TENAX THERAPEUTICS, INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.